TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive Retraction Based On Data Given To Duke Last November, But Apparently Disregarded October 29, 2010
TCL Archive Cancer Control Grows Up Fast As It Moves To Meet Mandate, Take Over Big Part Of NCI Budget March 15, 1974